期刊文献+

托烷司琼联合胃复安预防肿瘤化疗恶心、呕吐疗效的观察与护理 被引量:3

Observation of the Efficacy of Tropisetron Combined with Metoclopramide in Preventing Nausea and Vomiting during Tumor Chemotherapy
下载PDF
导出
摘要 目的探讨预防肿瘤化疗引起消化道反应的方法及有效护理措施。方法采用多中心、随机、自身交叉对照的方法,对330例中晚期肿瘤病人在行化疗时予以静脉使用托烷司琼(5mg)和肌注胃复安(20mg):观察组托烷司琼与胃复安联合应用、对照组Ⅰ单独用托烷司琼和对照组Ⅱ单独用胃复安,对预防肿瘤化疗后消化道反应的治疗效果进行对比观察及相关护理。结果观察组与两个对照组在预防化疗消化道反应的效果分别为:预防恶心有效率:72.7%(80/110)、51.8%(57/110)、20.9%(23/110);预防呕吐有效率分别为:94.5%(104/110)、70%(77/110)、40%(44/110)。观察组预防肿瘤化疗后消化道反应的效果明显优于对照组。结论两种止吐药物联合应用,对预防肿瘤化疗后胃肠道反应的作用明显优于两药单独使用。在化疗过程中严密观察药物副反应,做好患者心理护理,饮食护理,可使患者顺利完成化疗周期,提高生存质量。 Objective To inquire into the method of preventing the digestive symptoms during tumor chemotherapy and the effective nursing measure.Methods Three hundred and thirty patients with middle-late tumor were divided into 3 groups by the multicentric,random,selfcross method,who were given tropisetron(5mg) intravenously and metoclopramide(20mg) intramuscularly.Tropisetron was used in the observation group in combination with metoclopramide,tropiseton in control group Ⅰ and metroclopramide in control group Ⅱ.The efficacy of them in preventing the digestive symptoms during tumor chemotherapy was comparatively observed.Results The efficacy rate of preventing nausea was 72.7%(80/110) in the observation group,51.8%(57/110) in control group Ⅰand 20.9%(23/110) in control group Ⅱ and that of preventing vomiting,94.5%(104/110),70%(77/110) and 40%(44/110).The efficacy was significantly superior in the observation group to that in the control groups.Conclusions The effects of tropisetron used in combination with metoclopramide on the digestive symptoms during tumor chemotherapy are significantly superior to those of a single use drug.The close observation of drug side effects and the assurance of psychological and diet nursing of the patients can make them tide over a chemotherapeutic period successfully and improve the quality of their survival.
作者 朱秀辉
出处 《西南军医》 2010年第4期667-669,共3页 Journal of Military Surgeon in Southwest China
关键词 肿瘤化疗 托烷司琼 胃复安 消化道反应 tropisetron metoclopramide nausea vomiting
  • 相关文献

参考文献5

二级参考文献13

  • 1陈仲群,陈龙水,郑淦基.恩丹西酮与其他止呕药预防腹腔镜术后恶心呕吐的临床研究[J].中国医师杂志,2005,7(S1):355-356. 被引量:3
  • 2陈樱,刘克玄,肖颖,黄文起.三种5-HT_3受体拮抗剂对妇科病人术后恶心呕吐的影响[J].中山大学学报(医学科学版),2004,25(B07):251-253. 被引量:9
  • 3莫利求,冯霞,黄文起,何广芬,萧颖.托烷司琼与恩丹西酮对小儿术后恶心呕吐的预防作用[J].中华麻醉学杂志,2005,25(1):69-70. 被引量:12
  • 4Thongprasert S. Efficacy and tolerability of tropisetron in the prevention of cisplatin-induced nausea and vomiting in advanced non-small cell lung cancer[J]. Acta Oncol, 2000, 39(2): 221-224.
  • 5Sorbe BG,Hogberg T,Glimeliou B,et al. A randonaized, multicenter study comparing the efficacy and tolerability of tropisetron, a new 5-HT3 receptor antagonist, with a metoclopramide-containing antiemetic cocktail in the prevention of cisplatin-in ducedemesis[J]. Cancer, 1994, 73(2): 445-454.
  • 6Barbounis V, Koumakis G.The anti-em- etic efficacy of tropisetron plus dexamethasone in patients treated with high-dose chemotherapy and stem cell transplantation[J]. Support Care Cancer, 1999, 7(2): 79-83.
  • 7Marty M,Kleisbauer JP,Foumel P,et al. Is Navoban (tropisetron) as effective as Zofran (ondansetron) in cisplatin-induced emesis. The French Navoban Study Gro up. Anticancer Drugs[J]. 1995,6 Suppl 1:15-21.
  • 8马俊良,现代肿瘤内科手册,1996年,39页
  • 9CHUA DT,SHAM JS,KUONG DL,et al. comparative efficacy of 5-HT3 antagonists ( granisetron, andansetron and tropisetron ) plus dexamethasome for the prevention of cisplatin-induced acute emesis :a randomized crossover study [ J ]. Am J Clin Onco, 2000,23(2) :185 -191.
  • 10李峙,张还珠.化疗所致恶心、呕吐的防治和护理[J].现代临床医学生物工程学杂志,2000,6(2):72-72. 被引量:5

共引文献28

同被引文献11

引证文献3

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部